Rev Bras Anestesiol
2009; 59: 3: 344-349

INFORMAGAO CLINICA
CLINICAL REPORT

Mielinolise Pontina Central apos Transplante Hepatico:
oO Sodio E o Unico Vilao? Relato de Caso*
Central Pontine Myelinolysis after Liver Transplantation:
is Sodium the Only Villain? Case Report

Bruno Salomé de Morais, TSA', Fabiano Soares Carneiro, TSA', Rodolfo de Morais Araujo’,
Guilherme Freitas Araujo*, Rodrigo Bernardes de Oliveira‘

RESUMO

Morais BS, Carneiro FS, Araujo RM, Oliveira RB, Araujo GF -
Mielindlise Pontina Central apds Transplante Hepatico: o Sddio E o
Unico Vildo? Relato de Caso.

JUSTIFICATIVA E OBJETIVOS: A ocorréncia de sintomas neuro-
ldgicos em pacientes gravemente enfermos 6 comum e, muitas ve-
zes, um desafio propedéutico. Descrita ha cerca de 50 anos, a
desmielinizagao dos neurénios da regiao pontina é uma alteracao
patologica associada a quadros neuroldgicos e psiquiatricos apds
transplante hepatico. O objetivo deste relato foi apresentar a
mielinolise pontina central diagnosticada no pds-operatorio de
transplante hepatico e discutir sua fisiopatologia.

RELATO DO CASO: Paciente do sexo feminino, 29 anos, subme-
tida a transplante hepatico devido insuficiéncia hepatica fulminan-
te. No pds-operatorio apresentou quadro neuroldgico caracteristico
de Sindrome Locked In e lesédes compativeis com mielinolise
pontina central a ressonancia nuclear magnética. A paciente nao
apresentou oscilag¢des exageradas do sddio plasmatico, fon fre-
quentemente incriminado como agente causal, evoluindo com me-
lhora significativa em algumas semanas.

CONCLUSOES: A mielinélise pontina central tem etiologia
multifatorial e atencao especial deve ser dada ao grupo de paci-
entes com maior risco, tais como aqueles submetidos a alteragdées
abruptas da natremia, transplantados de figado, etilistas crénicos
e desnutridos. E importante reconhecer que as sindromes desmie-
linizantes osmoésticas podem surgir em pacientes com niveis
séricos de sddio baixo, normal ou elevado, evidenciando a contri-
bui¢cao de outros fatores desencadeantes.

Unitermos: CIRURGIA, Transplante: figado; COMPLICACOES: mie-
lindlise central da ponte.

* Recebido do (Received from) Servico de Anestesia para Transplante de Or-
gaos do Hospital das Clinicas da Universidade Federal de Minas Gerais (HC/
UFMG), Belo Horizonte, MG

1. Anestesiologista do Hospital Lifecenter e do Grupo de Transplante de Or-
gaos do HC/UFMG

2. ME, do CET de Anestesiologia do Hospital das Clinicas da UFMG

3. Graduando em Medicina pela UFMG; Académico da Iniciagao Cientifica

4. Anestesiologista do Grupo de Transplante de Orgaos do HC/UFMG;
Anestesiologista do Hospital Vila da Serra; Anestesiologista e Coordenador
da Residéncia de Anestesiologista do Hospital Semper

Apresentado (Submitted) em 11 de dezembro de 2008
Aceito (Accepted) para publicagcao em 9 de fevereiro de 2009

Enderego para correspondéncia (Correspondence to):
Dr. Bruno Salomé de Morais

Rua Donato da Fonseca 213/102

Cora¢ao de Jesus

30380-260 Belo Horizonte, MG

E-mail: brunomoraisanet@yahoo.com.br

344

SUMMARY

Morais BS, Carneiro FS, Araujo RM, Oliveira RB, Araujo GF — Cen-
tral Pontine Myelinolysis after Liver Transplantation: Is Sodium the Only
Villain? Case Report.

BACKGROUND AND OBJECTIVES: Critically ill patients
frequently develop neurologic symptoms, which frequently become
a Clinical challenge. Described approximately 50 years ago, pontine
neuronal demyelination is a pathologic change associated with
neurologic and psychiatric problems after liver transplantation. The
objective of this report was to present a case of central pontine
myelinolysis diagnosed after liver transplantation and to discuss its
pathophysiology.

CASE REPORT: A 29 years old female patient underwent liver
transplantation for fulminant hepatic failure. Postoperatively, she
developed neurologic symptoms characteristic of the Locked In
Syndrome and the MRI showed changes compatible with central
pontine myelinolysis. The patient did not develop dramatic changes
in sodium plasma levels, which is frequently incriminated as the cau-
sal agent, and improved considerably within a few weeks.

CONCLUSIONS: The etiology of central pontine myelinolysis is
multifactorial, and special attention should be given to the group of
patients at greater risk, such as those with sudden changes in the
plasma levels of sodium, liver transplantation, chronic alcoholics, and
malnourished. It is important to recognize that osmotic demyelination
can develop in patients with low, normal, or elevated plasma levels
of sodium, indicating the contribution of other trigger factors.

Keywords: COMPLICATIONS: central pontine myelinolysis; SUR-
GERY, Transplantation: liver.

INTRODUGAO

A mielindlise pontina central (MPC) € uma complicagao neu-
rologica grave e incomum caracterizada por desmielinizagao
aguda de neur6énios localizados na regiao centro-pontina,
acompanhada de manifestag6es graves e por vezes irre-
versiveis '. Apesar de se acreditar que a correcao rapida do
sddio plasmatico seja o principal fator causal 7, este relato
reforca que existem outros fatores relacionados ao apare-
cimento da MPC.

RELATO DO CASO

Trata-se de paciente feminina, 29 anos, 1,65m, 58 kg, MELD 40,
submetida a transplante hepatico ortotd6pico de doador cadaver

Revista Brasileira de Anestesiologia
Vol. 59, N° 3, Maio-Junho, 2009

----$$$$----$$$$----
MIELINOLISE PONTINA CENTRAL APOS TRANSPLANTE HEPATICO: O SODIO E O UNICO VILAO? RELATO DE CASO

por hepatopatia aguda fulminante. Encaminhada do CTI intu-
bada, em ventilagao mecanica ha 48 horas devido a deterio-
ragao do quadro neurologico e instabilidade hemodinamica.
A paciente foi monitorizada com eletrocardidgrafo, oximetro
de pulso, pressao intra-arterial, cateter de artéria pulmonar
com medidas continuas de débito cardiaco e saturacgao ve-
nosa mista de oxigénio. Tromboelastografia, eritrograma,
coagulograma, ionograma e gasometria arterial foram rea-
lizados periodicamente durante toda a intervengao cirurgica.
Foi mantida anestesia geral balanceada e infusao continua de
noradrenalina para manutengao de pressao arterial média
acima de 60 mmHg. A reposi¢ao volémica, guiada pelos
exames seriados, foi realizada com solugao de Ringer com
lactato com albumina a 5% e hemoderivados. A paciente evo-
luiu com estabilidade hemodinamica e viabilidade do enxerto,
sendo extubada 48 horas apos o transplante, quando apre-
sentou quadro neurologico caracterizado por tetraplegia e
anartria. Seguia o examinador com o olhar horizontal, mas nao
obedecia a ordens e apresentava sinal de Babinski bilate-
ralmente. Apds 24 horas, foi realizada ressonancia nuclear
magnetica (RNM) de cranio que evidenciou desmielinizagao
em regiao centro-pontina (Figura 1), firmando o diagnostico de
MPC. A paciente recuperou-se bem em poucas semanas e

Figura 1 — Ressonancia Magnética do Cranio. Imagem hiperintensa
em T, (axial) e hipointensa em T, (sagital), triangular e acaptante,
no centro geométrico da ponte. Conformagao em asa de
morcego observada no corte axial.

Tabela | — Evolugao da Natremia durante o Perioperatorio

Periodo Natremia (mEq.L”)
Veéspera da operacgao 138
Fase pré anepatica 133
Fase anepatica 136
Fase neohepatica 138
D 1 pds-operatorio 138
D 2 pds-operatorio 142
D 3 pods-operatorio 139

Revista Brasileira de Anestesiologia
Vol. 59, N° 3, Maio-Junho, 2009

teve alta hospitalar com leves disartria e dismetria. Apresen-
tou boa recuperacgao da forg¢a muscular e voltou a deambular
normalmente. O acompanhamento neuroldgico foi mantido
no pds-operatorio. Durante todo o periodo perioperatorio a
paciente nao apresentou alteragoes bruscas nos niveis
plasmaticos de sddio, conforme tabela |.

DISCUSSAO

Complicag6es neurologicas aparecem frequentemente apos
transplante hepatico, com incidéncia variando de 8% a
47% '°8. Essas complicagées, que incluem encefalopatias,
desordens cerebrovasculares, infeccdes, neurotoxicidade
induzida por imunossupressores e lesdes nervosas perifé-
ricas, podem ter grande influéncia na sobrevida e qualida-
de de vida do paciente '.

A MPC foi primeiramente descrita em 1959 °, sendo relatada
apos transplante hepatico em 1978 '°. Apresenta incidéncia
de 1,2% a 10% em receptores de figado, com alta incidéncia
de mortalidade ®"'. Por definicao, trata-se de desmieliniza-
cao nao-inflamatoria, frequentemente simétrica, concentra-
da no centro da ponte. Entretanto, em 10% dos casos, a
desmielinizagao também ocorre em regides extrapontinas,
tendo-se proposto o termo sindromes desmielinizantes
osmoticas (SDO) para tais situagdes 2'7. As SDO sao rapi-
damente progressivas e geralmente fatais. A MPC 6 a mais
grave complicagao neurologica apos o transplante hepatico,
com mortalidade acima de 50% nas duas primeiras sema-
nas e 90% em seis meses. Quando os pacientes sobrevi-
vem, a maioria apresenta deficits neuroldgicos ‘*"°.

A etiologia da desmielinizagao osmotica nao é bem entendida.
Embora a rapida corregao do sodio sérico na hiponatremia
tenha sido implicada como principal fator causal, o abuso de
alcool e transplante hepatico sao fortes fatores preditivos in-
dependentes *°. Outros fatores de risco estao sendo identifi-
cados, como insuficiéncia adrenal, desnutricao, faléncia renal
cronica e hemodialise, sepse e malignidades; podendo de-
senvolver-se na auséncia de flutuacdes do sddio sérico 177°.
A MPC é uma sindrome clinica caracterizada por tetraplegia
e paralisia pseudobulbar, frequentemente acompanhada por
depressao da consciéncia '%. Progressiva letargia, quadripa-
resia, disartria, oftalmoplegia, disfasia, ataxia e alteragdes dos
reflexos ocorrem em dois a sete dias apos o inicio do trata-
mento da doenga subjacente ou da corregao de disturbios
hidreletroliticos 7. Como consequéncia, um pseudocoma tipi-
co se desenvolve, também conhecido como sindrome locked-
in (tetraplegia, anartria, seguir 0 examinador com os olhos
sem obedecer suas ordens, sinal de Babinski positivo bila-
teralmente) '°. Embora possa ser reversivel, o curso clinico
usual 6 a progressao para Obito apds dias ou semanas °°.
Confirmagao radioldgica 6 necessaria para a exclusao de
outros diagnosticos e para determinagao da extensao do
processo de desmielinizagao. A tomografia computadorizada
pode subestimar a verdadeira extensao da doenga. O valor

345

----$$$$----$$$$----
MORAIS, CARNEIRO, ARAUJO E COL.

da ressonancia nuclear magnética (RNM) em determinar o
numero e a extensao das lesdes é de grande significancia,
apresentando leso6es desmielinizantes agudas simétricas
com hipointensidade em T, e hiperintensidade em T,, duran-
te a fase subaguda, devido as micro-hemorragias secunda-
riaS a presenga de injuria endotelial. As lesoes na RNM
aparecem dias ou semanas apdos 0 inicio dos sintomas °°.
As SDO s@ao caracterizadas pela dissolugcao das bainhas de
mielina, poupando os ax6énios nervosos. Surpreendente-
mente, ha auséncia de resposta inflamatoria, levando a su-
gestao de que a morte celular 6 mediada por apoptose ?”.
Células gliais, vulneraveis na MPC, tém significante papel no
controle da osmolalidade extracelular dos neurénios que
sustentam, utilizando a glicose como substrato metabodlico.
Durante a hiponatremia, na tentativa de diminuir o edema
celular, as células expulsam particulas osmoticamente ativas,
como a taurina, para reduzir o acumulo de agua intracelular *°.
No processo reverso, as células gliais ativam bombas de
Na*-K*ATPase para importar eletrolitos, as custas de gran-
de gasto metabdlico, utilizando toda a glicose disponivel '°.
Esse estresse metabolico resulta na liberagao de glutamato
e de outros neuromoduladores excitatorios, causando a
abertura de canais de calcio que, juntamente com a maior
producgao de radicais livres pelas mitoc6éndrias, iniciam o
processo apoptotico '*.Em pacientes com faléncia hepatica,
as células gliais nao tém um suprimento adequado de glico-
se ou glicogénio, portanto, pequenos desarranjos levam a
rapida deplecao de energia e morte celular 7. Osmolitos or-
ganicos protegem o encéfalo de rapidas mudang¢as na
osmolalidade sérica. Pacientes hepatopatas tém deficién-
cia de mioinositol, um importante osmolito, tornando-os
susceptiveis a MPC. Além do mais, tais pacientes encon-
tram-se em balango nitrogenado negativo, diminuindo a
quantidade de aminoacidos disponiveis para a formacao de
osmolitos organicos essenciais (taurina, creatina) ®. Fator de
risco adicional é€ a hipocalemia, pois aumenta o potencial de
acao contra o qual a ATPase deve operar '°. Modelos animais
demonstraram que os niveis encefalicos de fosfocreatina,
creatina, mioinositol, glicerofosforilcolina, taurina, glutamato
e glutamina diminuem em 24 horas apos o inicio da
hiponatremia, mas se reacumulam lentamente durante a
terapia corretiva, independentemente do ritmo de corregao
da natremia. Esse fato explica porque nivel normal de sddio
nao exclui o diagnéstico de SDO *.

A predilegao da ponte nas SDO deve-se ao arranjo dos
neur6énios e células gliais em conformagao linear rigida, for-
cando as células a perderem mais osmolitos como mecanis-
mo adaptativo, pois nao podem se edemaciar. Tal arranjo
também limita o estoque e transporte de glicose, devido a
maior demanda metabolica e pior perfusao sanguinea, ja que
esta se da apenas por ramos perfurantes da artéria basilar *°.
Nenhum tratamento especifico tem se mostrado capaz de
interromper ou reverter o progresso das SDO. Embora rela-
tos de casos isolados sugiram que esteroides, hormdénios
liberadores de tireotropina e plasmaférese ‘7° possam ser

346

uteis, tais tratamentos necessitam de maior fundamentacao,
visto que nenhum trabalho com distribuigao aleatoria dos
pacientes comprovou sua eficacia. Varias diretrizes 11:19:16.2"
sobre a adequada reposicao de sddio em pacientes hipo-
natrémicos ja foram publicadas, devendo-se evitar sua ele-
vacgao acima de 12 mEq.L" nas primeiras 24 horas. Uma
abordagem adequada sugerida é repor o deéficit de sddio de
0,5 a 1 mEq.L".h" e nao exceder a natremia de 130 mEq.L"
nas primeiras 48 horas:. Apesar do paciente, no presente
caso, nao ter apresentado hiponatremia importante, a vari-
acao do sddio foi inferior a 10 mEq.L' em 24 horas, duran-
te toda internagao. Ha uma escassez de recomendagoes
para se tratar individuos com sddio sérico normal.

Até o momento, a prevengao da desmielinizagao osmotica
é o esteio do tratamento. A visao predominante (originada
grandemente de estudo de casos) € que individuos com um
ou mais fatores de risco (doenga sistémica grave, alcoolis-
mo, transplante hepatico, desnutrigao) devem ser submeti-
dos a frequentes exames neuroldgicos, juntamente com
exames de imagem. SDO devem ser consideradas em pa-
cientes que nao se recuperam como esperado de uma en-
fermidade grave ou em pacientes que manifestam novos
sintomas psiquiatricos depois de um quadro grave.
Recomenda-se que nos pacientes de alto risco deve-se evi-
tar o estresse metabolico com reposicao de tiamina e, se
necessaria correcao do sddio, fazé-la lentamente. Deve-se
realizar controle glicémico rigoroso, dialise pré-operatoria
nos nefropatas e correcao de fons, além da correcao de ou-
tros fatores exacerbantes 2.

Destaca-se, portanto, que a MPC tem uma etiologia multi-
fatorial, relacionada em parte ao estresse osmodtico neuronal
e glial e, em parte, a deficiéncias no suprimento energético
glial/neuronal e sua utilizagao, culminando com o processo
de apoptose celular '*. Outro ponto relevante é que a reposi-
cao lenta de sddio na hiponatremia crénica é fundamental
para a prevencao desta doenga, porem atencao especial deve
ser dada a grupo de pacientes de maior risco como os trans-
plantados de figado, etilistas cr6nicos e desnutridos. E impor-
tante reconhecer que as SDO podem surgir em pacientes
com niveis séricos de sodio baixo, normal ou elevado.

Central Pontine Myelinolysis after Liver
Transplantation: is Sodium the Only
Villain? Case Report

Bruno Salomé de Morais, TSA, M.D.; Fabiano Soares Carnei-
ro, TSA, M.D.; Rodolfo de Morais Araujo, M.D.; Rodrigo
Bernardes de Oliveira, M.D.; Guilherme Freitas Araujo, M.D.

INTRODUCTION

Central pontine myelinolysis (CPM) is a rare and severe neu-
rologic complication characterized by acute central pontine

Revista Brasileira de Anestesiologia
Vol. 59, N° 3, Maio-Junho, 2009

----$$$$----$$$$----
CENTRAL PONTINE MYELINOLYSIS AFTER LIVER TRANSPLANTATION: IS SODIUM THE ONLY VILLAIN? CASE REPORT

neuronal demyelination along with severe and occasionally
irreversible manifestations '. Although it is believed that fast
correction of the plasma levels of sodium is the main cau-
se 7, this report supports the presence of other factors related
to the development of CPM.

CASE REPORT

This is a 29-year old female, 1.65 m, 58 kg, MELD 40, who
underwent orthotopic liver transplantation from a dead donor
by reason of a fulminant liver failure. The patient was
transferred to the ICU intubated and on mechanical ventila-
tion for 48 hours due to worsening of her neurologic condition
and hemodynamic instability.

The patient was monitored with electrocardiogram, pulse
oximeter, intra-arterial blood pressure, pulmonary artery
catheter with continuous measurements of the cardiac output
and mixed venous oxygen saturation. Thromboelastography,
erythrogram, coagulogram, blood electrolytes, and arterial
blood gases were done periodically during the surgery. She
was maintained with balanced general anesthesia and
continuous infusion of noradrenaline to maintain mean ar-
terial pressure above 60 mmHg. Ringer’s lactate, 5%
albumin, and blood products were administered according
to the results of serial exams. The patient evolved with hemo-
dynamic stability and transplant viability. She was extubated
48 hours after the transplant, when she developed neuro-
logic changes with quadriplegia and anarthria. She followed
movements with horizontal eye movements, but she did not
followed commands, and Babinski sign was positive bila-
terally. After 24 hours, and magnetic ressoance imaging (MRI)
of the head showed central pontine demyelination (Figure 1),
confirming the diagnosis of CPM. The patient recovered in a
few weeks, being discharged from the hospital with mild
dysarthria and dysmetria. She presented good recovery of the
muscle strength and was walking normally. Neurologic
follow-up continued throughout the postoperative period.

Figure 1 — MRI of the Head. Hyperdense image on T2 (axial) and
hypodense in T1 (sagittal), triangular and without capture, at the
geometric center of the pons. Bat-wing shape seen on axial
view.

Revista Brasileira de Anestesiologia
Vol. 59, N° 3, Maio-Junho, 2009

Table | — Perioperative Evolution of Sodium Serum Levels

Period Sodium Levels (mEq.L")
Day before surgery 138
Pre-anhepatic phase 133
Anhepatic phase 136
Neohepatic phase 138
D 1 postoperative 138
D 2 postoperative 142
D 3 postoperative 139

During the entire perioperative period, the patient did not
develop sudden changes in the plasma levels of sodium, as
shown in Table I.

DISCUSSION

Neurologic complications are frequent after liver transplan-
tation, with an incidence between 8% and 47% '*°. Those
complications, which include encephalopathies, cerebro-
vascular disorders, infections, immunosupressor-induced
neurotoxicity, and peripheral nerve lesions can influence
considerably survival and quality of life of patients *.

Central pontine myelinolysis was first described in 1959 ° and
in 1978 reported after liver transplantation '°. It has an incidence
that ranges from 1.2% to 10% in liver transplant recipients,
with a high mortality rate ®:. By definition, it is a non-inflam-
matory, frequently symmetrical central pontine demyelination.
However, in 10% of the cases demyelination also affects ex-
tra-pontine areas, and the term osmotic demyelination
syndrome (ODS) was proposed for such cases *:'7. Osmotic
demyelination syndromes are rapidly progressive and
usually fatal. Central pontine myelinolysis is the most severe
post-liver transplantation neurologic complication with a
mortality rate higher than 50% in the first two weeks and 90%
in six months. When patients survive most of them have
neurologic deficits '*"°.

The etiology of osmotic demyelination is not well unders-
tood. Although rapid correction of serum sodium levels in
hyponatremia have been implicated as the main cause,
alcohol abuse and liver transplantation are strong indepen-
dent risk factors '*. Other risk factors such as adrenal insuf-
ficiency, mal nutrition, chronic renal failure and hemodialysis,
sepsis, and neoplasms are being identified and it can deve-
lop in the absence of fluctuations in sodium serum levels 17°.
Central pontine myelinolysis is a clinical syndrome charac-
terized by quadriplegia and pseudobulbar paralysis, and it is
frequently associated with loss of consciousness ‘°. Progres-
sive lethargy, quadriparesis, dysarthria, ophthalmoplegia,
dysphasia, ataxia, and changes in reflexes develop two to
seven days after the onset of the treatment of the underlying

347

----$$$$----$$$$----
MORAIS, CARNEIRO, ARAUJO ET AL.

disease or correction of hydrolelectrolytic imbalance '*. As a
consequence, a typical pseudocoma, also known as the
locked-in syndrome (quadriplegia, anarthria, a capacity to
follow the examiner with the eyes but not to follow command,
bilateral Babinski sign) develops ‘’. Although it can be rever-
sible the patient usually dies after several days or weeks °°.
Radiological confirmation is necessary to exclude other
diagnosis and to determine the exact extension of the de-
myelination. Computed tomography can underestimate the
real extension of the disease. Magnetic resonance imaging
plays a fundamental role in the determination of the number
and extension of the lesions showing acute, symmetrical
demyelinating lesions, with hypointensity in T, and hyperinten-
sity in T, in the subacute phase due to microhemorrhages
secondary to endothelial damage. Lesions are visible on MRI
a few days or weeks after the onset of the symptoms *.
Osmotic demyelinating syndromes are characterized by the
dissolution of myelin shafts, sparing the axons. Surprisin-
gly, inflammation is absent suggesting that cell death is by
apoptosis 2. Glial cells vulnerable on CPM play an important
role in controlling the extracellular osmolality of the neurons
they support using glucose as a metabolic substrate. During
hyponatremia, in an attempt to reduce cellular edema, cells
expel osmotically active particles such as taurine to reduce
the amount of intracellular water '®. In the reverse process,
glial cells activate Na*-K*ATPase pumps to import electroly-
tes at the expense of a high metabolic cost using all glucose
available '®. This metabolic stress results in the release of
glutamate and other excitatory modulators that cause the
opening of calcium channels, which, along with the increased
production of free radicals by the mitochondria, start the
process of apoptosis ‘. In patients with liver failure, glial cells
do not have adequate glucose or glycogen supply and,
therefore, small derangements lead to energy depletion and
cell death 7. Organic osmolytes protect the brain from sudden
changes in serum osmolality. Patients with liver disease
have a deficiency of myo-inositol, an important osmolyte, be-
coming susceptible to CPM. Besides, those patients present
negative nitrogen balance decreasing the amount of amino
acids available to form essential organic osmolytes (taurine,
creatine) ®°. Hypocalcemia represents an additional risk factor
because it increases the action potential against which
ATPAse has to work ‘. Animal models demonstrated that
brain levels of phosphocreatine, creatine, myo-inositol, glyce-
rophosphorylcholine, taurine, glutamate, and glutamine
decrease 24 hours after the beginning of hyponatremia, but
accumulate again slowly during corrective treatment in-
dependently of the rate of correction of sodium levels. This
explains why normal sodium levels do not exclude the diag-
nosis of ODS *.

Osmotic demyelinating syndromes have a predilection for
the pons because in this structure neurons and glial cells
are arranged in a strict linear configuration forcing cells to
lose more osmolytes as an adaptive mechanism, since they
cannot become edematous. This set up also limits glucose

348

storage and transportation due to greater metabolic needs
and worse perfusion, since it is done only by perforating
branches of the basilar artery.

Specific treatments capable of interrupting or reverting the
progress of ODS do not exist. Although isolated reports that
corticosteroids, thyrotropin releasing hormones, and plas-
mapheresis ‘7° can be useful, those treatments need more
support, since there are no randomized studies proving their
efficacy. Several guidelines ‘'*'®21 on adequate sodium
administration to hyponatremic patients have been publi-
shed and one should avoid raising it above 12 mEq.L" in the
first 24 hours. A proper approach would be to administer 0.5
to 1.0 mEq.L".h" without exceeding sodium levels of 130
mEq.L" in the first 48 hours. Although the patient presented
here did not develop important hyponatremia, sodium chan-
ges were lower than 10 mEq.L" in 24 hours throughout
hospitalization. Recommendations on treating individuals
with normal serum levels are lacking.

Currently, treatment consists basically on preventing osmotic
demyelination. The predominating view (based mainly on case
reports) is that individuals with one or more risk factors (Severe
systemic disease, alcoholism, liver transplantation, malnu-
trition) should undergo frequent neurological exams, along
with imaging exams. The diagnosis of osmotic demyelinating
syndrome should be considered in patients who do not
recover as expected from a severe disease or in patients who
develop new psychiatric symptoms after being severely ill.
Avoiding metabolic stress with administration of thiamine and
if necessary slow correction of the serum levels of sodium
are recommended in high-risk patients. Strict control of glu-
cose levels, preoperative dialysis in patients with renal failure,
and correction of electrolytes levels and other exacerbating
factors are recommended 2.

Central pontine myelinolysis has a multifactorial etiology,
partly related to neuronal and glial osmotic stress, and partly
to deficiencies on glial/neuronal energy supply and use
culminating in the process of cellular apoptosis '. Slow cor-
rection of chronic hyponatremia is fundamental for the pre-
vention of this disorder; however, special attention should be
given to the group of patients with higher risk factors like liver
transplantations, alcoholism, and mal nutrition. It is important
to recognize that ODS can affect patients with low, normal, or
elevated serum levels of sodium.

REFERENCIAS — REFERENCES

01. Kim BS, Lee SG, Hwang S et al. - Neurologic complications in
adult living donor liver transplant recipients. Clin Transplant 2007;
21:544-547.

02. Huq S, Wong M, Chan H et al. - Osmotic demyelination
syndromes: central and extrapontine myelinolysis. J Clin Neurosci
2007;14:684-688.

03. Lewis MB, Howdle PD - Neurologic complications of liver
transplantation in adults. Neurology 2003;61:1174-1178.

04. Lopez OL, Estol C, Colina | et al. - Neurological complications
after liver retransplantation. Hepatology 1992;16:162-166.

Revista Brasileira de Anestesiologia
Vol. 59, N° 3, Maio-Junho, 2009

----$$$$----$$$$----
05.

06.

07.

08.

09.

10.

11.

12.

13.

14.

15.

16.

17.

18.

CENTRAL PONTINE MYELINOLYSIS AFTER LIVER TRANSPLANTATION: IS SODIUM THE ONLY VILLAIN? CASE REPORT

Sterzi R, Santilli 1, Donato MF et al. - Neurologic complications
following orthotopic liver transplantation. Transplant Proc 1994;
26:3679-3680.

Burkhalter EL, Starzl TE, Van Thiel DH - Severe neurological
complications following orthotopic liver transplantation in patients
receiving FK 506 and prednisone. J Hepatol 1994;21:572-577.
Ghaus N, Bohlega S, Rezeig M - Neurological complications in
liver transplantation. J Neurol 2001;248:1042-1048.

Bronster DJ, Emre S, Boccagni P et al. - Central nervous system
complications in liver transplant recipients: incidence, timing,
and long-term follow-up. Clin Transplant 2000;14:1-7.

Adams RD, Victor M, Mancall EL - Central pontine myelinolysis:
a hitherto undescribed disease occurring in alcoholic and
malnourished patients. AMA Arch Neurol Psychiatry 1959;81:
154-172.

Starzl TE, Schneck SA, Mazzoni G et al. - Acute neurological
complications after liver transplantation with particular referen-
ce to intraoperative cerebral air embolus. Ann Surg 1978;187:
236-240.

Yu J, Zheng SS, Liang TB et al. - Possible causes of central
pontine myelinolysis after liver transplantation. World J Gastro-
enterol 2004;10:2540-2543.

Soupart A, Ngassa M, Decaux G - Therapeutic relowering of the
serum sodium in a patient after excessive correction of hypona-
tremia. Clin Nephrol 1999;51:383-386.

Sterns RH, Baer J, Ebersol S et al. - Organic osmolytes in acute-
hyponatremia. Am J Physiol 1993;264:F833-836.

Newell KL, Kleinschmidt-DeMasters BK - Central pontine
myelinolysis at autopsy; a twelve year retrospective analysis. J
Neurol Sci 1996;142:1394-1399.

Brown WD - Osmotic demyelination disorders: central pontine
and extrapontine myelinolysis. Curr Opin Neurol 2000;13:691-
697.

Ashrafian H, Davey P - A review of the causes of central ponti-
ne myelinosis: yet another apoptotic illness? Eur J Neurol 2001;
8:103-109.

Taneja K, Sabharwal RK, Taneja A et al. - Central pontine mye-
linolysis in a normonatremic child. Indian Pediatr 1997;34:153-
156.

Mast H, Gordon PH, Mohr JP et al - Central pontine myelinolysis:
clinical syndrome with normal serum sodium. Eur J Med Res 1995;
1:168-170.

Revista Brasileira de Anestesiologia
Vol. 59, N° 3, Maio-Junho, 2009

19. Ardizzone G, Arrigo A, Schellino MM et al. - Neurological com-
plications of liver cirrhosis and orthotopic liver transplant. Trans-
plant Proc 2006;38:789-792.

20. Grimaldi D, Cavalleri F, Vallone S et al. - Plasmapheresis improves
the outcome of central pontine myelinolysis. J Neurol 2005;252:
734-735.

21. Snell DM, Bartley C - Osmotic demyelination syndrome following
rapid correction of hyponatraemia. Anaesthesia 2008;63:92-95.

RESUMEN

Morais BS, Carneiro FS, Araujo RM, Oliveira RB, Araujo GF - Mie-
lindlisis Pontina Central después del Transplante Hepatico: ¢Es el
sodio el unico villano? Relato de Caso.

JUSTIFICATIVA Y OBJETIVOS: El aparecimiento de sintomas neu-
roldgicos en pacientes gravemente enfermos es comun y muchas
veces, es un reto propedéutico. Descrita hace cerca de 50 afios, la
desmielinizacion de las neuronas de la region pontina, es una alte-
racion patologica asociada a cuadros neuroldgicos y psiquiatricos
posteriores al transplante hepatico. El objetivo de este relato, fue
presentar la mielinolisis pontina central diagnosticada en el
postoperatorio de transplante hepatico y discutir su fisiopatologia.

RELATO DEL CASO: Paciente del sexo femenino, 29 anos,
sometida a transplante hepatico debido a un fracaso hepatico ful-
minante. En el postoperatorio, present6 un cuadro neuroldgico ca-
racteristico de Sindrome Locked In y lesiones compatibles con la
mielinolisis pontina central a la resonancia nuclear magnética. La
paciente no presento oscilaciones exageradas del sodio plasma-
tico, que es el ion frecuentemente acusado de ser el agente causa-
dor, y evolucioné con una mejoria significativa en algunas semanas.

CONCLUSIONES: La mielindlisis pontina central tiene una etiologia
multifactorial, y una atenci6n especial debe darsele al grupo de pa-
cientes con mayor riesgo, tales como los sometidos a alteraciones
abruptas de la natremia, transplantados de higado, etilistas
cronicos y desnutridos. Es importante reconocer, que los sindromes
de desmielinizaci6n osmosticos pueden surgir en pacientes con ni-
veles séricos de sodio bajo, normal o elevado, evidenciando la
contribucion de otros factores desencadenantes.

349

----$$$$----$$$$----
